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ABSTRACT
Objective: To evaluate neonatal outcomes of pregnancies complicated by early-onset pre-
eclampsia (PE) and compare these outcomes to those of gestational age matched neonates born
to mothers whose pregnancy was not complicated by early-onset PE.
Methods: We analyzed the outcome in 97 neonates born to mothers with early-onset PE (24–32
weeks amenorrhea at diagnosis) and compared it to that of 680 gestational age-matched neo-
nates born between 25–36 weeks due to other etiologies and admitted to the Neonatal
Intensive Care Unit (NICU) of a tertiary referral hospital in the Netherlands. We used Chi-square
test, Wilcoxon test, and logistic regression analyses.
Results: Neonates born to PE mothers had a higher perinatal mortality (13% vs. 7%, p¼ 0.03)
and infant mortality (16% vs. 9%, p¼ 0.03), a 20% lower birth weight (1150 vs. 1430g, p<0.001),
were more often SGA (22% vs. 9%, p< 0.001) and had more neonatal complications as com-
pared to neonates born to mothers without PE.
Conclusions: Overall adverse perinatal outcome is significantly worse in neonates born to moth-
ers with early-onset PE. The effect of early-onset PE on perinatal mortality seems partially due to
SGA. Whether these differences are due to uteroplacental factors or intrinsic neonatal factors
remains to be elucidated.
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Introduction
In the Netherlands, yearly about 12,000 women (6–7%)
deliver before 37 weeks gestation, of which 1500
deliver before 32 weeks gestation. Preterm delivery is
an important cause of perinatal mortality and morbid-
ity [1], mainly due to neurological sequelae. The per-
centage of medically induced preterm deliveries is
rising at a steeper rate than spontaneous preterm
deliveries. Pregnancies that are complicated by hyper-
tensive disorders, contribute to this rise. About 16% of
pregnancies in the Netherlands are complicated by
pregnancy induced hypertension (PIH) and 2% by pre-
eclampsia (PE) [1]. PE is characterized by hypertension
with proteinuria. Pregnancies complicated by PE con-
tribute to maternal and perinatal mortality and mor-
bidity [2,3]. All reported studies recommended
intensive fetal surveillance for early detection of fetal
compromise. Delivery of the fetus and placenta remain
to date the only causal treatment. There is a broad
agreement to terminate pregnancy when maternal or
fetal conditions are altered or once 34 weeks of gesta-
tion are reached [4]. But early-onset PE poses a man-
agement dilemma. Delivery may benefit the mother,
but may harm a premature fetus. Expectant manage-
ment in women with early-onset PE before 34 weeks’
gestation may reduce neonatal complications and stay
in a Neonatal Intensive Care Unit (NICU), [4,5] but
could aggravate the maternal condition [3,4].
It is uncertain whether neonatal outcome in PE
mothers is determined by prematurity itself, by PE
complications or other main factors. Gestational hyper-
tension occurring early in pregnancy is associated with
a higher rate of small for gestational age (SGA) infants
and lower gestational age at delivery when compared
to late gestational hypertension in previous studies [6].
SGA is often caused by uteroplacental insufficiency,
which is associated with PIH. In addition, pregnancies
complicated by early-onset PE are associated with the
highest rate of SGA neonates comparing to PIH,
suggesting the influence of the pathophysiology of
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early-onset PE on fetal outcome in hypertensive dis-
eases [7]. Maternal lifestyle [8], congenital malforma-
tions and chronic maternal (kidney) disease [9] are also
etiologic factors of SGA. Less is known of the impact
of early-onset PE on perinatal mortality. Previous stud-
ies have shown differences in the prevalence of peri-
natal mortality most likely as a result of
methodological etiology or power [10,11].
Therefore, the aim of this study was to address neo-
natal outcome in women with early-onset PE and com-
pare these outcomes to those of gestational age
matched premature neonates born to women not
affected by early-onset PE.
Materials and methods
All medical records of singleton pregnancies with
early-onset PE (gestational age 24–32 weeks at diagno-
sis for the current study) admitted to the Obstetric
High Care (OHC) unit of the Radboud University
Medical Center Nijmegen (Netherlands) between
January 2008 and December 2011 were studied. We
excluded pregnancies complicated by congenital
anomalies that have a significant impact on survival
and neonatal complications.
The definitions of hypertension and proteinuria
used were those described in Dutch guidelines and
the guideline of the Royal College of Obstetricians and
Gynecologists produced by the National Collaborating
Center for Women’s and Children’s Health (NCC-WCH)
on behalf of the National Institute of Health and Care
Excellence (NICE) [12]. Briefly, PE is defined as a
combination of blood pressure 140/90mmHg and
proteinuria 0.3 g total protein within a 24-h urine col-
lection, or ratio of protein to creatinine 0.03g/mmol.
Perinatal outcome was defined as a composite of
mortality and variables of neonatal morbidity.
Mortality was divided into perinatal mortality, occur-
ring within the first 28 days of life, and infant mortal-
ity, occurring within the first year of life. We defined
perinatal complications as infant respiratory distress
syndrome (IRDS), use of surfactant therapy, clinical
sepsis with positive blood culture, stage I, II or III
necrotizing enterocolitis [13] (NEC), grades III or IV
intraventricular hemorrhage [14] (IVH) and grades II, III
or IV periventricular leukomalacy [15] (PVL) diagnosed
by utrasonographic examination. Stage I–V retinopathy
of prematurity (ROP) was defined as abnormal vaso-
proliferation and tortuosity, retinal ridge, scarring and
retinal detachment. Pneumothorax was diagnosed by
radiographic findings. Furthermore, we registered
Apgar scores after 1 and 5minutes and the neonatal
birth weight. We defined SGA as a birth weight below
the 10th percentile of the new Dutch reference curves
for birth weight by gestational age corrected for parity
and gender [16].
Statistical methods
To determine the effect of early-onset PE on the end-
points described earlier, we made a comparison
between neonates born to PE mothers and to non-PE
mothers, which we defined as controls (non-PE neo-
nates). Patients admitted for suspected fetal distress or
placental abruption were excluded. We used the
Radboud University Medical Center NICU-registration
between January 2008 and December 2011 to collect
the data from the control group that consisted of ges-
tational age-matched neonates at delivery.
Differences between groups were evaluated with the
Chi-square test for dichotomous and with the Wilcoxon
test for continuous variables. Odds ratios and adjusted
odds ratios were calculated using logistic regression
analysis. Statistical analysis was performed using SPSS
22.0 statistical software (IBM Corp., Armonk, NY), a
p values of <0.05 was considered significant.
This study did not need approval of our ethical
committee because it was a retrospective collection of
data in women who received standard management
at the hospital.
Results
Maternal characteristics
We registered 109 patients with early-onset PE of which
78% were nulliparous. Mean gestational age at diagno-
sis was 29 ± 2 weeks. Mean maternal age was 30± 5
years (17–41 years) and the ethnic origin of 81% of this
study group was Dutch. There were no maternal deaths
reported. According to the hospital guidelines, tempo-
rizing treatment was given to PE mothers consisting of
antepartum corticosteroids (81% of cases) to accelerate
fetal lung maturation in addition to antihypertensive
treatment. The median of days gained by temporizing
management was 6 days (range 1–52 days). All mothers
delivered after 25 weeks amenorrhea.
Neonatal characteristics
A total of 109 neonates were born to early-onset PE
mothers and were admitted to the NICU department.
Three neonates were excluded from statistical analysis
because of missing data. There was one case of
fetal death. A further eight neonates were excluded
because of severe congenital anomalies, as microceph-
aly (1), gastrointestinal atresia (1), diaphragmatic
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hernia (1), chromosomal anomalies (1), lung hypoplasia
(1), tuberous sclerosis (1), congenital hypothyroidism
(1) and colpocephaly (1). The perinatal outcome of the
remaining 97 neonates was analyzed (Table 1).
The control group consisted of 739 gestational age-
matched neonates born with other etiologies that
were admitted to the NICU during the same study
period. Fifty-nine neonates were excluded from ana-
lysis because of severe congenital anomalies. Most
prevalent anomalies were gastrointestinal atresia (10),
microcephaly (5), diaphragmatic hernia (3), chromo-
somal anomalies (5), renal diseases (8) and lung hypo-
plasia (3). Perinatal outcome of the remaining 680
neonates was analyzed (Table 1).
Perinatal outcome
While the median gestational age at delivery was simi-
lar, the birth weight of early-onset PE neonates was
significantly lower as compared to non-PE neonates
(1150 g vs. 1430 g, p< 0.001). PE neonates were more
often SGA at birth as compared to non-PE neonates
(22% vs. 9%, p< 0.001). Perinatal mortality (13% vs.
7%, p¼ 0.03) and infant mortality (16% vs. 9%,
p¼ 0.03) of PE neonates were significantly higher as
compared to controls. Using logistic regression ana-
lysis, the odds ratio for perinatal mortality was 2.038
(95% CI: 1.06–3.92) when comparing the PE group
with the controls cases, and odds ratio for infant mor-
tality was 1.962 (95% CI: 1.06–3.62). Fifteen neonates
died in the PE group, of which thirteen in the first 28
days after delivery.
Perinatal mortality was further evaluated by SGA
subgroup analysis (Figure 1). In PE pregnancies, peri-
natal mortality was 29% in infants born SGA compared
to 9% of infants born non SGA (p¼ 0.02). In non-PE
infants, perinatal mortality was also higher in the SGA
group (19% vs. 6%, p< 0.001). Using logistic regression
analysis the adjusted effect of PE correcting for SGA
revealed an odds ratio of 1.640 (95% CI: 0.831–3.235)
for perinatal mortality, indicating that the difference of
0.4 in OR is due to SGA. A comparison of these analy-
ses suggests that the effect of PE on perinatal mortal-
ity is partially due to SGA. In the control group, SGA
infants also showed a higher perinatal mortality.
Perinatal mortality was also analyzed according to
sex. In both PE- and non-PE pregnancies, gender had
no significant influence on the perinatal mortality rate
(male 7% vs. female 17%, p¼ 0.17 in PE pregnancies
and male 8% vs. female 7%, p¼ 0.60, in non-PE
pregnancies).
Furthermore, the incidence of some neonatal com-
plications was increased in PE neonates. In particular,
IRDS (62% vs. 50%, p¼ 0.045) and sepsis (43% vs. 30%,
p< 0.01) occurred more often in PE neonates than in
non-PE neonates. No differences between groups were
found for pneumothorax, PVL, IVH or ROP (Table 2).
Discussion
This study shows that neonatal outcome in pregnan-
cies complicated by early-onset PE differs from that of
age-matched NICU neonates born to mothers not
affected by PE. Early-onset PE neonates are more often
Table 1. Perinatal outcome.
PE neonates Non-PE neonates
N¼ 97 N¼ 680 p values
Gestational age at delivery (weeks) 30 [25–36] 30 [25–36] 0.89
Male gender 41 (43) 344 (51) 0.18
Female gender 56 (57) 336 (49) 0.18
1min Apgars score 7 [1–10] 7 [0–10] 0.30
5min Apgars score 9 [0–10] 8 [0–10] 0.015
Birth weight (grams) 1150 [400–2710] 1430 [480–4147] 0.001
SGA (<p10) 21 (22) 58 (9) 0.001
Cesarean section 64 (66) 226 (34) 0.001
Perinatal mortality 13 (13) 48 (7) 0.03
Infant mortality 15 (16) 58 (9) 0.03
Data are number of patients (%) or median [range].
p values of <0.05 was considered significant and indicated in italic font.
Figure 1. Perinatal mortality rate among PE vs. non-PE neo-
nates according to SGA subgroup analysis.
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SGA at birth, and perinatal and infant mortality and
morbidity are increased. These results demonstrate the
adverse effects of early-onset PE on the overall peri-
natal outcome and demonstrate the impact of early-
onset PE as a proxy for perinatal survival.
Neonatal growth
Neonatal outcome in pregnancies complicated by PE
is mostly related to gestational age at delivery, [17,18]
and gestational age is the strongest predictor of peri-
natal mortality and morbidity [19]. This study demon-
strates that early-onset PE is a strong variable for
perinatal outcome in premature neonates. Previous
studies suggest that maternal hypertension and PE
cause a reduced utero-placental perfusion and, conse-
quently, impaired fetal growth [20,21]. The former
could be explained by the lack of spiral artery remod-
eling that leads to high velocity pulsatile blood flow
and syncytiotrophoblast damage. In established severe
disease, acute atherosis leads to reduced utero-placen-
tal perfusion. The concomitant raised blood pressure,
related to increased release of sFlt-1, could be inter-
preted as a fetal attempt to raise maternal blood pres-
sure in order to increase perfusion pressure [22]. The
present study shows that PE neonates born between
25 and 36 weeks’ gestation have a 20% lower birth
weight and a twofold higher rate of SGA (22% vs. 9%)
than preterm infants born with similar gestational ages
without maternal early-onset PE. These findings are in
accordance with previous reports [7,10,21,23]. For
example, Jelin et al. [10], in a cohort of 235 women
affected by early onset PE, also found a threefold
higher rate of SGA neonates as compared to non-PE
women (18% vs. 6%). Whether this is related to the
time of onset of PE was studied in a Norwegian popu-
lation by Rasmussen et al. [23]. They compared the
effect of early- versus late-onset PE on birth weight
and found an 11–23% reduced birth weight in early-
onset PE neonates. This is in accordance with our
study, where we report a 20% reduction.
Perinatal mortality
Regarding perinatal mortality rate, early-onset PE is
associated with an almost twofold increase in perinatal
death as compared to non-PE pregnancies in our
study cohort. The increased perinatal mortality is con-
gruent with the increased rate of SGA. SGA is corre-
lated with a higher mortality rate and is an important
predictor for perinatal survival [24]. In the present
study cohort, early-onset PE pregnancies are associ-
ated with a higher mortality rate (29%) in infants born
SGA compared to SGA infants in the non-PE group
(19%). Regression analysis showed the effect of early-
onset PE on perinatal mortality is mainly due to SGA.
Besides, there could be common causes of SGA and
mortality that we cannot make visual for bias correc-
tion. Explaining by the ‘birth weight paradox’ in
Hernandez-Diaz et al. [25], adjustment for birth weight
is unwarranted when the analytical goal is to estimate
overall effects of perinatal variables on infant mortality.
Even for estimating direct effects of prenatal variables,
adjustment for birth weight may be invalid when
there is an unmeasured common cause of SGA and
mortality.
Jelin et al. [10] described a 9% decrease in perinatal
mortality in pregnancies complicated by PE as com-
pared to the control group of other preterm deliveries
(11% vs. 18%, p¼ 0.008) refuting previous studies that
demonstrated no difference in perinatal survival [26].
One explanation for this decrease could be the relative
high incidence of preterm premature rupture of mem-
branes in the control group. Preterm premature rup-
ture of membranes carries the highest neonatal
morbidity of all etiologies of preterm labor [27].
Withagen et al. [11], who evaluated temporizing treat-
ment in PE-pregnancies to assess its effect on neonatal
outcome, found a 33% lower birth weight and higher
rate of SGA neonates (52% vs. 3.2%) in PE pregnancies
as compared to gestational age-matched non-PE con-
trol group. No significant difference was found in peri-
natal or infant mortality. The perinatal mortality rate in
PE pregnancies in the present study population is
higher (13% vs. 7%) compared to that of Withagen
et al. and may be explained by the shorter mean tem-
porization treatment (8 days vs. 14 days). In accord-
ance with our study, Withagen et al. also observed a
Table 2. Neonatal complications.
PE neonates Non-PE neonates
N¼ 97 N¼ 680 p values
IRDSa 56 (62) 342 (50) 0.045
Surfactant treatmenta 45 (50) 226 (33) 0.002
Pneumothoraxa 3 (3) 17 (3) 0.67
Sepsisa 41 (43) 204 (30) 0.01
Intracranial hemorrhagea 0.77
grade I 13 (14) 103 (15)
grade II 1 (1) 13 (2)
grade III–IV 0 (0) 0 (0)
Periventricular leukomalaciaa 0.50
grade I 11 (12) 96 (14)
grade II–IV 0 (0) 0 (0)
Retinopathya 0.66
grade I 5 (6) 26 (4)
grade II 0 (0) 2 (0.3)
grade III–V 0 (0) 0 (0)
Necrotizing enterocolitisa 0.92
stage I–III 9 (9) 61 (9)
Data are number of patients (%).
aSome patients match more than one complication.
Some data (N¼ 7) are missing.
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better prognosis in infants born to mothers without
early-onset PE.
Perinatal morbidity
In this study, infants born to mothers with early-onset
PE were more likely to develop IRDS, with 62% of
infants affected versus 50% in the control group, which
is in accordance with others [10,28]. The postnatal
course of early-onset PE neonates was more often com-
plicated by sepsis (43% vs. 30%) compared to non-PE
neonates. The increased risk of IRDS could at least be
partially related to the higher frequency of cesarean
delivery (66% vs. 35%, p<0.001) in women with PE
[29,30], despite the treatment of ante partum cortico-
steroids in 81% of cases. Witlin et al. [28] concluded in
a cohort of 195 PE pregnancies that respiratory distress
syndrome was inversely related to gestational age at
delivery and directly related to cesarean delivery.
Werner et al. [30] also reported increased odds of
respiratory distress and sepsis in preterm neonates in
cesarean compared with vaginal delivery.
Our study has some limitations, because it is a
retrospective study. Therefore, our results should be
interpreted with caution. However, the results show a
worsened perinatal outcome in early-onset PE. In 2001,
Withagen et al. [11] showed the benefit of temporizing
treatment in neonatal outcome in PE pregnancies. As
of 2016, despite all efforts, non-PE neonates still have
a better outcome than infants born to mothers with
early-onset PE. A previous attempt to address this
issue in a randomized controlled trial was initiated in
the Netherlands in which the risks of maternal compli-
cations by temporizing treatment in women with
early-onset PE and the subsequent benefits for the
neonate at 24 to 32 weeks’ gestation were weighed
[31]. Due to disappointing inclusion, the study did not
meet inclusion targets and was canceled.
In summary, this study shows that neonatal outcome
of infants born to mothers with early-onset PE is worse
than that of infants born to mothers with other etiolo-
gies of preterm labor. Specifically, these infants were
more often SGA and their mortality and neonatal com-
plication rates were greater. This information can be
used in the counseling of women with early-onset PE.
Whether these differences are attributed to SGA alone
or another yet unsolved pathophysiological mechanism
remains unclear and warrant additional investigation.
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